Post COVID-19 vaccine (SINOVAC) cerebral venous sinus thrombosis
Pakistan Journal of Neurological Sciences · 2022
DOI: 10.56310/pjns.v17i02.185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Neurological Sciences, 2022. Verfasst von Soban Khan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Sinovac is an inactivated virus COVID 19 vaccine given emergency authorization for COVID 19 Pandemic. Different adverse reactions have been seen in after marketing of COVID 19 vaccines. Here we present a case of patient who developed cerebral venous sinus thrombosis two weeks after the first dose of SINOVAC vaccine.
Zitieren
APA
Khan, S., Khalil, M., & Waqar, Z. (2022). Post COVID-19 vaccine (SINOVAC) cerebral venous sinus thrombosis. Pakistan Journal of Neurological Sciences. https://doi.org/10.56310/pjns.v17i02.185
Vancouver
Khan S, Khalil M, Waqar Z. Post COVID-19 vaccine (SINOVAC) cerebral venous sinus thrombosis. Pakistan Journal of Neurological Sciences. 2022. doi:10.56310/pjns.v17i02.185
BibTeX
@article{Khan2022,
author = {Khan, Soban and Khalil, Mariam and Waqar, Zaid},
title = {Post COVID-19 vaccine (SINOVAC) cerebral venous sinus thrombosis},
journal = {Pakistan Journal of Neurological Sciences},
year = {2022},
doi = {10.56310/pjns.v17i02.185}
}
EUVIMED